This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Interquim, S.a.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Antonio Abelino De León Martín: Innovator in Pharmaceutical Processes
Introduction
Antonio Abelino De León Martín is a notable inventor based in Bellaterra, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of complex compounds. His work is characterized by innovative processes that enhance the efficiency and effectiveness of drug development.
Latest Patents
Antonio holds a patent for a process for the preparation of aripiprazole lauroxil. This process involves reacting 1-(hydroxymethyl) aripiprazole with lauric acid in the presence of a suitable solvent and a carboxyl activating agent. Additionally, the preparation of 1-(hydroxymethyl) aripiprazole is achieved by reacting aripiprazole or its hydrate with paraformaldehyde, utilizing an organic solvent and a base, without adding water to the reaction mixture. This innovative approach contributes to the pharmaceutical industry's efforts in developing effective treatments.
Career Highlights
Antonio is associated with Interquim, S.A., where he applies his expertise in pharmaceutical processes. His work has been instrumental in advancing the company's capabilities in drug formulation and development. His dedication to innovation has positioned him as a key figure in his field.
Collaborations
Antonio collaborates with talented professionals such as Marta Pomares Marco and Francisco De Asís Marquillas Olondriz. These collaborations enhance the research and development efforts within the company, fostering a creative environment for innovation.
Conclusion
Antonio Abelino De León Martín exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patented processes are paving the way for advancements in drug development. His work not only reflects his expertise but also his commitment to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile